Glucagon-like peptide-1 receptor agonists, a type of diabetes medication, could potentially aid in preserving fertility for obese patients with endometrial cancer by lowering body mass index, inflammation, and insulin resistance, hence increasing likelihood of future pregnancy. This evidence concerns the gene GLP1R and diabetes mellitus.